Altro Health Raises $7M Seed for Wellness Infrastructure

A blood-test result brings a different kind of judgment into a wellness business. The coach may know the client's routines, but interpreting that result belongs to a licensed clinician. Altro Health is building the software and coordination that let those people work around the same customer relationship, with clinical services accessible through the wellness business's brand.

The New York company announced a $7M financing on October 6, 2026, led by NFX with Founder Collective and Abby Miller Levy of Primetime Partners participating. The seed round backs an infrastructure business serving coaches, fitness studios, medspas and wellness centers. CEO Andrea Corleto and COO Jennifer Arnold built Altro after operating their own virtual longevity clinic, Lyv Health.

The funding disclosure puts a commercial question close to the medical one: how much of an expanding wellness customer's journey can stay with the business that already knows them? Altro supplies access to independent providers and the tools to coordinate that journey. Its opportunity depends on making the clinical handoff understandable to the client and workable for the business owner.

From running a clinic to supplying other operators

Andrea Corleto and Jennifer Arnold's earlier clinic made them responsible for assembling services around individual clients. Altro turns that coordination into something other businesses can buy. That is a consequential change in customer: the founders now serve operators who already have relationships, rather than building every consumer relationship themselves.

NFX's investment account identifies Andrea Corleto as CEO and Jennifer Arnold as COO, says the founders met at Harvard Business School, and dates the company to 2025. The investor describes Altro's addressable customer as the small health, wellness and fitness business that wants to add medical services. That gives the company a distribution route through existing businesses, each with its own reason to preserve a client relationship.

The financing news also has two calendars. In the founder's announcement shared by Altro, Andrea Corleto said the company had been building for 6 months after raising the money. NFX's memo is dated June 2026. October 6 is therefore the public announcement date used here; the disclosed record does not establish an October closing or an exact earlier close date.

Altro says the proceeds support more product offerings and more wellness businesses across the US. The company has not disclosed a valuation, a detailed allocation of the round, or independently verified revenue in the sources reviewed. For its founders, a broader offering means more services to coordinate inside someone else's business, with that operator's reputation traveling alongside the product.

The storefront and the clinical decision have different owners

Altro's service workflow combines a branded storefront, patient portal, payment processing, lab access, licensed clinicians and pharmacy coordination. Clients can request reviews and track services through the portal. The clinician reviews medical information and decides whether prescribing is appropriate; pharmacies fulfill prescriptions. A familiar logo can organize the experience while medical decisions remain with qualified providers.

Altro explicitly identifies itself as a technology and coordination company. Its website states that independent licensed providers deliver medical services and that Altro does not provide medical care or operate as a pharmacy. That boundary matters to an operator evaluating the product: adding a storefront does not turn the owner of a gym or coaching business into a prescriber.

The published pricing page displays a Starter plan equivalent to $319 per month, billed at $957 every 3 months, and a Pro plan equivalent to $599 per month, billed at $1,797 every 3 months. Pro adds an own-domain storefront and additional marketing and service features. Those are the displayed quarterly-billing terms, rather than a claim about every available payment option.

For a small business, the subscription turns a coordination project into a recurring operating expense. The owner can assess whether the added services help retain clients and support the cost of the offering. Altro has not published retention or margin evidence in these sources, so those commercial benefits remain questions for customers to evaluate as their own client activity develops.

Investor conviction meets the responsibilities of clinical access

NFX General Partner James Currier describes the investment in terms of a platform serving businesses that already meet consumers. His thesis is that a growing provider network could improve purchasing terms and service breadth. It is an investor's account of potential scale, with no disclosed measurement establishing the size or strength of those network effects today.

Founder Collective General Partner Amanda Herson, quoted in Altro's announcement, emphasizes the value of a trusted human relationship as consumers navigate more complex wellness offerings. Those perspectives converge on distribution through an existing relationship. They also explain why the founders' clinic experience matters commercially: the product has to connect several independent participants without leaving a client unsure who is making the medical decision.

Altro's company overview reports 5,000+ users and nationwide state availability. These are company-reported measures of adoption and reach, rather than revenue, business-customer retention or evidence of clinical effectiveness. They give prospective operators a sense of the platform's stated footprint while leaving the economics and outcomes of individual services to separate assessment.

Access to a clinician also needs to be distinguished from approval of a medication. The FDA's explanation of compounding states that compounded drugs are not FDA-approved and have not received the agency's premarket review for safety, effectiveness and quality. Clinical supervision and licensed fulfillment should be described accurately without converting them into a blanket safety or approval claim.

Altro's expansion will put those distinctions inside more branded customer experiences. A wellness owner can remain the person a client knows while another professional reviews the medical question. Andrea Corleto and Jennifer Arnold are financing the work between those participants, including the moments when a client needs to know which person is responsible for the next decision.